<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Alphacetylmethadol</id>
	<title>Alphacetylmethadol - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Alphacetylmethadol"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Alphacetylmethadol&amp;action=history"/>
	<updated>2026-04-25T08:07:22Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Alphacetylmethadol&amp;diff=5369277&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Alphacetylmethadol&amp;diff=5369277&amp;oldid=prev"/>
		<updated>2024-03-06T06:21:36Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Alphacetylmethadol.svg|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Alphacetylmethadol&amp;#039;&amp;#039;&amp;#039; (also known as &amp;#039;&amp;#039;&amp;#039;ACEM&amp;#039;&amp;#039;&amp;#039; or &amp;#039;&amp;#039;&amp;#039;LAAM&amp;#039;&amp;#039;&amp;#039;) is a synthetic [[opioid]] used in the treatment of [[opioid addiction]]. It is a long-acting derivative of [[methadone]] and is chemically similar to [[levo-alpha-acetylmethadol]] (LAAM).&lt;br /&gt;
&lt;br /&gt;
== History ==&lt;br /&gt;
Alphacetylmethadol was first synthesized in the 1940s as part of a research program aimed at developing opioid analgesics with improved pharmacological properties. It was later developed as a treatment for opioid addiction in the 1970s.&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
Alphacetylmethadol is a [[mu-opioid receptor]] agonist. It works by mimicking the effects of opioids in the brain, thereby reducing cravings and withdrawal symptoms in opioid-dependent individuals. Alphacetylmethadol is metabolized in the liver and has a long half-life, which allows for less frequent dosing compared to other opioid replacement therapies.&lt;br /&gt;
&lt;br /&gt;
== Clinical Use ==&lt;br /&gt;
Alphacetylmethadol is used in the treatment of opioid addiction. It is typically administered in a clinic setting under the supervision of a healthcare provider. The dosage is individualized based on the patient&amp;#039;s opioid tolerance and response to treatment.&lt;br /&gt;
&lt;br /&gt;
== Side Effects ==&lt;br /&gt;
Common side effects of alphacetylmethadol include constipation, drowsiness, and nausea. Serious side effects may include respiratory depression, QT prolongation, and dependence.&lt;br /&gt;
&lt;br /&gt;
== Legal Status ==&lt;br /&gt;
In the United States, alphacetylmethadol is classified as a Schedule II controlled substance, indicating a high potential for abuse and dependence.&lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
* [[Methadone]]&lt;br /&gt;
* [[Opioid addiction]]&lt;br /&gt;
* [[Opioid replacement therapy]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Opioids]]&lt;br /&gt;
[[Category:Drugs used in opioid addiction]]&lt;br /&gt;
[[Category:Synthetic opioids]]&lt;br /&gt;
{{Opioids}}&lt;br /&gt;
{{Pharmacology-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>